Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 11/20 | 0.67 |
| ▸ | PPARG | P37231 | 8/20 | 0.67 |
| ▸ | PPARD | Q03181 | 2/20 | 0.43 |
| ▸ | TLR7 | Q9NYK1 | 8/20 | 0.43 |
| ▸ | FBP1 | P09467 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6512175 | 1.00 | PPARA (0.67) | PPARAPPARGPPARDTLR7FBP1 | |
| SCHEMBL6510721 | 0.95 | PPARA (0.61) | PPARAPPARGPPARDTLR7 | |
| SCHEMBL6513058 | 0.95 | PPARA (0.60) | PPARAPPARGPPARDTLR7 | |
| SCHEMBL6512166 | 0.95 | PPARA (0.60) | PPARAPPARGPPARDTLR7 | |
| SCHEMBL6511438 | 0.95 | PPARA (0.60) | PPARAPPARGPPARDTLR7 | |
| SCHEMBL6533130 | 0.94 | PPARA (0.64) | PPARAPPARGPPARDTLR7 | |
| SCHEMBL6509731 | 0.94 | PPARA (0.64) | PPARAPPARGPPARDTLR7 | |
| SCHEMBL6512786 | 0.94 | PPARA (0.64) | PPARAPPARGPPARDTLR7 | |
| SCHEMBL6514571 | 0.94 | PPARA (0.62) | PPARAPPARGPPARDTLR7 | |
| SCHEMBL6511817 | 0.94 | PPARA (0.62) | PPARAPPARGPPARDTLR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005080354-A1 | 1,2,4-TRIAZINES DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN HUMAN THERAPEUTICS | PIERRE FABRE MEDICAMENT (FR) | 2005-09-01 | — | — | WO | claimed |
| EP-1292595-A1 | 5-(4-(2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY)BENZYL)THIAZOLIDINE-2,4-DIONE HYDRIODIDE AS PHARMACEUTICAL | SMITHKLINE BEECHAM PLC (GB) | 2003-03-19 | — | — | EP | claimed |
| WO-2001094343-A1 | 5-(4-(2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY)BENZYL)THIAZOLIDINE-2,4-DIONE HYDRIODIDE AS PHARMACEUTICAL | SMITHKLINE BEECHAM P.L.C. (GB) | 2001-12-13 | — | — | WO | claimed |
| WO-2005080354-A1 | 1,2,4-TRIAZINES DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN HUMAN THERAPEUTICS | PIERRE FABRE MEDICAMENT (FR) | 2005-09-01 | — | — | WO | disclosed |
| EP-1509249-A2 | INCLUSION COMPLEXES OF ROSIGLITAZONE | GLAXO GROUP LIMITED (GB) | 2005-03-02 | — | — | EP | disclosed |
| WO-2003099337-A2 | INCLUSION COMPLEXES OF ROSIGLITAZONE | GLAXO GROUP LIMITED (GB) | 2003-12-04 | — | — | WO | disclosed |
| EP-1332142-A1 | SODIUM SALTS OF 5-[4-[2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY]B ENZYL]THIAZOLIDINE-2,4-DIONE | SmithKline Beecham p.l.c. (GB) | 2003-08-06 | — | — | EP | disclosed |
| EP-1292595-A1 | 5-(4-(2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY)BENZYL)THIAZOLIDINE-2,4-DIONE HYDRIODIDE AS PHARMACEUTICAL | SMITHKLINE BEECHAM PLC (GB) | 2003-03-19 | — | — | EP | disclosed |
| WO-2002026735-A1 | SODIUM SALTS OF 5-'4-'2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY]BENZYL]THIAZOLIDINE-2,4-DIONE | SMITHKLINE BEECHAM P.L.C. (GB) | 2002-04-04 | — | — | WO | disclosed |
| WO-2001094343-A1 | 5-(4-(2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY)BENZYL)THIAZOLIDINE-2,4-DIONE HYDRIODIDE AS PHARMACEUTICAL | SMITHKLINE BEECHAM P.L.C. (GB) | 2001-12-13 | — | — | WO | disclosed |